PDS Biotechnology Newsroom

PDS Biotechnology Analyst Ratings

BenzingaNov 26 00:46

B.Riley Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Cuts Target Price to $7

Futu NewsNov 25 21:32

PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow JonesNov 16 03:36

Noble Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $17

Futu NewsNov 15 22:31

H.C. Wainwright Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $21

Futu NewsNov 15 19:31

H.C. Wainwright Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $21

Futu NewsOct 24 18:31

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX) and PDS Biotechnology (PDSB)

TipRanksOct 7 21:57

Noble Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $17

Futu NewsOct 7 20:33

H.C. Wainwright Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $21

Futu NewsOct 2 23:31

PDS Biotechnology Analyst Ratings

BenzingaOct 2 23:19

Noble Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $17

Futu NewsSep 17 20:31

PDS Biotechnology (PDSB) Receives a Buy From Noble Financial

TipRanksSep 17 20:10

HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $21 Price Target

BenzingaSep 17 18:43

H.C. Wainwright Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $21

Futu NewsSep 17 18:31

Buy Rating Justified: PDS Biotechnology's Versamune HPV Shows Promise in Phase 2 Trials

TipRanksSep 17 18:17

PDS Biotechnology Analyst Ratings

BenzingaAug 21 00:08

A. G. P. Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Cuts Target Price to $7

Futu NewsAug 20 19:33

Noble Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $17

Futu NewsAug 14 21:33

PDS Biotechnology Analyst Ratings

BenzingaAug 2 04:25

HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $21 Price Target

BenzingaAug 2 04:24